KEYNOTE-365 cohort B updated results: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza) pre-treated patients with metastatic castration-resistant prostate cancer (mCRPC)

• G. Gravis,
• M. Kolinsky,
• L. Mourey,
• J.M. Piulats,
• S. Sridhar,
• E. Romano,
• W. Berry,
• H. Gurney,
• M. Retz,
• L. Appleman,
• M. Boegemann,
• J. De Bono,
• A. Joshua,
• U. Emmenegger,
• H. Conter,
• B. Laguerre,
• H. Wu,
• C. Schloss,
• C. Poehlein,
• E.Y. Yu

Affiliations

G. Gravis

M. Kolinsky

L. Mourey

J.M. Piulats

S. Sridhar

E. Romano

W. Berry

H. Gurney

M. Retz

L. Appleman

M. Boegemann

J. De Bono

A. Joshua

U. Emmenegger

H. Conter

B. Laguerre

H. Wu

C. Schloss

C. Poehlein

E.Y. Yu